Yellow Fever Vaccine

The yellow fever vaccine used must be approved by WHO .

使用的黄热病疫苗必须经世卫组织批准。

You also need proof of a Yellow Fever vaccine .

另外，你需要有黄热病疫苗的证明喔。

He could have a severe reaction to the yellow fever vaccine .

这样他就有可能对黄热病疫苗有反应。

Nursing care of a patient with visceral injury caused by injection of yellow fever vaccine

1例黄热病疫苗引发的嗜内脏损害反应患者的护理

How to Distinguish Populations for Inadvisable Inoculation of Yellow Fever Vaccine

如何鉴别不宜接种黄热病疫苗的人群

Administering yellow fever vaccine in endemic countries as part of routine infant immunization at the age of nine months ;

在呈地方性流行的国家，在九个月龄时接种黄热病疫苗，作为婴儿常规免疫的一部分；

WHO is the Secretariat for the International Coordinating Group for Yellow Fever Vaccine Provision ( ICG ) .

世卫组织担当黄热病疫苗供应国际协调小组的秘书处。

In1988 , WHO first recommended that at-risk countries incorporate yellow fever vaccine into the routine childhood immunization programmes .

1988年，WHO首次建议，处在危险中的国家应将黄热病疫苗纳入常规儿童免疫计划。

He could have a severe reaction to the yellow fever vaccine , and he won 't be getting out of bed , let alone leaving the country .

对黄热病疫苗，他会有严重过敏反应，连床都下不了，更别说什么出国了。

A critical and unresolved issue is the safety and efficacy of yellow fever vaccine in human subjects infected with immunodeficiency virus ( HIV ) .

黄热病疫苗在人免疫缺陷病毒（HIV）感染者中的安全性和效能一直是一个非常重要但尚未解决的问题。

The yellow fever vaccine is safe and affordable , providing effective immunity against yellow fever within one week for95 % of those vaccinated .

黄热病疫苗是安全的，且收费适宜，可使95%的疫苗接种者在一周内产生有效抵御黄热病的免疫力。

Trinidad and Tobago was the first country in the Americas to introduce yellow fever vaccine in the national immunization programme in1980 .

特立尼特和多巴哥是1980年美洲第一个把黄热病疫苗引人其国家免疫规划的国家。

The request has been reviewed and accepted by the International Coordinating Group and1.7 million doses of yellow fever vaccine will be arriving in Sudan next week .

该要求已经国际协调小组审查和接受，170万剂黄热病疫苗将于下周抵达苏丹。

Objective To discuss the Severe Adverse Vaccine-Associated Disease ( SAVAD ) after yellow fever vaccine , the risk factors , susceptible people and the preventing and controlling methods .

目的探讨黄热病疫苗接种所致严重不良反应、引起不良反应的危险因子、危险人群及结合工作实际提出防控措施。

GAVI-funded vaccines released by the International Coordinating Group on Yellow Fever Vaccine Provision ( YF-ICG ) for the2010 country mass preventive campaign will be used .

将使用黄热病疫苗供应国际协调小组（YF-ICG）为2010年国家大众预防活动提供的由全球疫苗和免疫联盟资助的疫苗。

The country has requested support from the International Coordinating Group on Yellow Fever Vaccine Provision ( YF-ICG ), which manages the global emergency stockpile of yellow fever vaccine .

该国已经要求黄热病疫苗供应国际协调小组（YF-ICG）提供支持，该小组管理全球黄热病疫苗应急储备。

There needs to be a better estimate of the risk , and prediction of subjects at risk and of factors predisposing to risk of both types of serious complication of the yellow fever vaccine .

有必要更好地评估危险，预测危险较高的个体，并预测在接种后嗜内脏型和嗜神经型这两种严重并发症的易发因素。

The1.7 million doses of yellow fever vaccine from the Global Alliance for Vaccines and Immunization ( GAVI ) emergency vaccine stockpile arrived in Sudan this week-end .

从全球疫苗和免疫联盟应急疫苗储存提供的170万剂黄热病疫苗于本周末抵达苏丹。

Live vaccines , such as oral poliovirus vaccine ; yellow fever vaccine ; and measles , mumps and rubella vaccines , do not contain thiomersal , because it would kill the immunizing component .

一些活疫苗，比如口服脊髓灰质炎疫苗；黄热病疫苗；麻疹，腮腺炎和风疹疫苗并不含硫柳汞，因为后者会杀死免疫成分。

Completed Sequences Analysis on the Chinese Attenuated Yellow Fever 17D Vaccine Strain and the WHO Standard Yellow Fever 17D Vaccine Strain

中国黄热疫苗减毒株和世界卫生组织黄热疫苗标准株基因全序列分析

The Yellow Fever ( YF ) vaccine , an attenuated yellow fever 17D ( YF-17D ) live vaccine , is one of the most effective and safest vaccines in the world and is regarded as one of the best candidates for viral expression vector .

黄热疫苗是一种减毒的黄热病毒17D（YF-17D）活疫苗，是现有疫苗中最安全、最有效的疫苗之一，适于发展为疫苗载体。

This preventive campaign was part of the global Yellow Fever Initiative which aims to prevent yellow fever epidemics and secure adequate yellow fever vaccine supply for Africa .

这次预防性活动是全球黄热病行动的组成部分，该行动的目标是预防黄热病流行，并使非洲获取足够的黄热病疫苗供应。